Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Additional mechanism of action for IGN-311: inhibition of growth factor signaling

Aug. 4, 2003

AVE-8062A: a tumor vasculature targeting agent with promising antitumor activity

Aug. 4, 2003

New nuclear hormone receptor modulators synthesized at BMS

Aug. 4, 2003

Camptothecin encapsulated in cationic liposomes targets tumor blood vessels

Aug. 4, 2003

MOR-201 program discontinued in Q2 at MorphoSys

Aug. 4, 2003

Neovascular targeting therapy developed at Munich Biotech

Aug. 1, 2003

New phase II trial studies of Genasense in combination with rituximab/fludarabine for CLL

Aug. 1, 2003

Aventis and ImmunoGen combine forces to develop anticancer therapeutics

Aug. 1, 2003

Human breast cancer growth inhibited by nocturnal melatonin

July 31, 2003

Evidence of antitumor effects of DMXAA in refractory solid tumors

July 31, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...